Authority Library / SSA / listings/11.00-neurological-disorders

Neurological Disorders

Aggregated by Superinsight from public-domain sources, as of 2026-08-20.

Listing 11.02 — Epilepsy

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.02

11.02 Epilepsy, documented by a detailed description of a typical seizure and characterized by A, B, C, or D:

A. Generalized tonic-clonic seizures (see 11.00H1a), occurring at least once a month for at least 3 consecutive months (see 11.00H4) despite adherence to prescribed treatment (see 11.00C); or

B. Dyscognitive seizures (see 11.00H1b), occurring at least once a week for at least 3 consecutive months (see 11.00H4) despite adherence to prescribed treatment (see 11.00C); or

C. Generalized tonic-clonic seizures (see 11.00H1a), occurring at least once every 2 months for at least 4 consecutive months (see 11.00H4) despite adherence to prescribed treatment (see 11.00C); and a marked limitation in one of the following:

  1. Physical functioning (see 11.00G3a); or

  2. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  3. Interacting with others (see 11.00G3b(ii)); or

  4. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  5. Adapting or managing oneself (see 11.00G3b(iv)); or

D. Dyscognitive seizures (see 11.00H1b), occurring at least once every 2 weeks for at least 3 consecutive months (see 11.00H4) despite adherence to prescribed treatment (see 11.00C); and a marked limitation in one of the following:

  1. Physical functioning (see 11.00G3a); or

  2. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  3. Interacting with others (see 11.00G3b(ii)); or

  4. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  5. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.03 — [Reserved]

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.03

11.03 [Reserved]

Listing 11.04 — Vascular insult to the brain, characterized by A, B, or C:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.04

11.04 Vascular insult to the brain, characterized by A, B, or C:

A. Sensory or motor aphasia resulting in ineffective speech or communication (see 11.00E1) persisting for at least 3 consecutive months after the insult; or

B. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities, persisting for at least 3 consecutive months after the insult; or

C. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a) and in one of the following areas of mental functioning, both persisting for at least 3 consecutive months after the insult:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.05 — Benign brain tumors, characterized by A or B:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.05

11.05 Benign brain tumors, characterized by A or B:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.06 — Parkinsonian syndrome, characterized by A or B despite adherence to prescribed treatment for at least 3 consecutive months (see 11.00C):

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.06

11.06 Parkinsonian syndrome, characterized by A or B despite adherence to prescribed treatment for at least 3 consecutive months (see 11.00C):

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.07 — Cerebral palsy, characterized by A, B, or C:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.07

11.07 Cerebral palsy, characterized by A, B, or C:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)); or

C. Significant interference in communication due to speech, hearing, or visual deficit (see 11.00E2).

Listing 11.08 — Spinal cord disorders, characterized by A, B, or C:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.08

11.08 Spinal cord disorders, characterized by A, B, or C:

A. Complete loss of function, as described in 11.00M2, persisting for 3 consecutive months after the disorder (see 11.00M4); or

B. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities persisting for 3 consecutive months after the disorder (see 11.00M4); or

C. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a) and in one of the following areas of mental functioning, both persisting for 3 consecutive months after the disorder (see 11.00M4):

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.09 — Multiple sclerosis, characterized by A or B:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.09

11.09 Multiple sclerosis, characterized by A or B:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.10 — Amyotrophic lateral sclerosis (ALS) established by clinical and laboratory findings

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.10

11.10 Amyotrophic lateral sclerosis (ALS) established by clinical and laboratory findings (see 11.00O).

Listing 11.11 — Post-polio syndrome, characterized by A, B, C, or D:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.11

11.11 Post-polio syndrome, characterized by A, B, C, or D:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Unintelligible speech (see 11.00E3); or

C. Bulbar and neuromuscular dysfunction (see 11.00F), resulting in:

  1. Acute respiratory failure requiring mechanical ventilation; or

  2. Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter; or

D. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.12 — Myasthenia gravis, characterized by A, B, or C despite adherence to prescribed treatment for at least 3 months

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.12

11.12 Myasthenia gravis, characterized by A, B, or C despite adherence to prescribed treatment for at least 3 months (see 11.00C):

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Bulbar and neuromuscular dysfunction (see 11.00F), resulting in:

  1. One myasthenic crisis requiring mechanical ventilation; or

  2. Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter; or

C. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.13 — Muscular dystrophy, characterized by A or B:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.13

11.13 Muscular dystrophy, characterized by A or B:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.14 — Peripheral neuropathy, characterized by A or B:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.14

11.14 Peripheral neuropathy, characterized by A or B:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.15 — [Reserved]

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.15

11.15 [Reserved]

Listing 11.16 — [Reserved]

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.16

11.16 [Reserved]

Listing 11.17 — Neurodegenerative disorders of the central nervous system, such as Huntington's disease, Friedreich's ataxia, and spinocerebellar degeneration, characterized by A or B:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.17

11.17 Neurodegenerative disorders of the central nervous system, such as Huntington's disease, Friedreich's ataxia, and spinocerebellar degeneration, characterized by A or B:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.18 — Traumatic brain injury, characterized by A or B:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.18

11.18 Traumatic brain injury, characterized by A or B:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities, persisting for at least 3 consecutive months after the injury; or

B. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following areas of mental functioning, persisting for at least 3 consecutive months after the injury:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).

Listing 11.19 — [Reserved]

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.19

11.19 [Reserved]

Listing 11.20 — Coma or persistent vegetative state, persisting for at least 1 month

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.20

11.20 Coma or persistent vegetative state, persisting for at least 1 month.

Listing 11.21 — [Reserved]

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.21

11.21 [Reserved]

Listing 11.22 — Motor neuron disorders other than ALS, characterized by A, B, or C:

20 C.F.R. Pt. 404, Subpt. P, App. 1, § 11.22

11.22 Motor neuron disorders other than ALS, characterized by A, B, or C:

A. Disorganization of motor function in two extremities (see 11.00D1), resulting in an extreme limitation (see 11.00D2) in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities; or

B. Bulbar and neuromuscular dysfunction (see 11.00F), resulting in:

  1. Acute respiratory failure requiring invasive mechanical ventilation; or

  2. Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter; or

C. Marked limitation (see 11.00G2) in physical functioning (see 11.00G3a), and in one of the following:

  1. Understanding, remembering, or applying information (see 11.00G3b(i)); or

  2. Interacting with others (see 11.00G3b(ii)); or

  3. Concentrating, persisting, or maintaining pace (see 11.00G3b(iii)); or

  4. Adapting or managing oneself (see 11.00G3b(iv)).